Ledger.Open graph →
SEC Form D · filed January 6, 2009

NeuroTherapeutics Pharma, Inc

Offering
$5.8M
Sold
$3.2M
Exemption
—
Industry
Biotechnology
Location
CHICAGO, IL
Type
—

People & firms on this filing (9)

Stephen D. Collins, M.D., Ph.D · Chicago, ILExec · DirectorHolli A. Carlson · Chicago, ILExecStephen D. Collins, M.D., Ph.D · CHICAGO, ILExec · DirectorKaren Boezi · Chicago, ILDirectorHeath Lukatch, Ph.D · Chicago, ILDirectorPhillip F. Morgan, Ph.D · Chicago, ILDirectorBrian B. Williams · Chicago, ILExecHolli A. Carlson · CHICAGO, ILExecStephen P. Wanaski, Ph.D · Chicago, ILExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗